| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
DOK1 |
DOK1: Docking protein 1 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
MAPRE1 |
MAPRE1: Microtubule-associated protein RP/EB family member 1 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
EIF3S6 |
EIF3S6, INT6: Eukaryotic translation initiation factor 3 subunit 6 |
0.66 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
STK10 |
STK10: Uncharacterized protein STK10 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
STK38 |
STK38, NDR1: Serine/threonine-protein kinase 38 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
SNX17 |
SNX17, KIAA0064: Sorting nexin-17 |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
0.66 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
0.66 |
Evidence |
|
| EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
0.66 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
0.66 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
ANAPC5 |
ANAPC5, APC5: Anaphase-promoting complex subunit 5 |
0.66 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
0.66 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
0.66 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CCNB1 |
Cyclin B1 |
0.66 |
Evidence |
O
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
MSH6 |
MSH6, GTBP: DNA mismatch repair protein MSH6 |
0.66 |
Evidence |
|